Supply Chain | November 27, 2021
Pharma firms switch to advanced pharma manufacturing
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The consideration for the acquisition is US $ 2.25 million
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
The order strengthens the company’s position in the East African market
The trial will be conducted across 10 sites in India
The drug is also intended for the treatment of glioblastoma multiforme
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
Subscribe To Our Newsletter & Stay Updated
